Elena del Alcázar Viladomiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elena del Alcázar Viladomiu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Anna Tuneu Valls
Department of Dermatology, Hospital Universitario Donostia, San Sebastián, Spain
3 shared publicationsA Valls
2 shared publicationsA. López-Pestaña
Servicio de Dermatología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
2 shared publicationsA. Tuneu-Valls
Servicio de Dermatología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
2 shared publicationsA Moreno
1 shared publicationA Pestaña
1 shared publication
Latest Publications
- Open Access
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)
Background: Tildrakizumab, an anti-IL-23p19 monoclonal antibody, has demonstrated efficacy in clinical trials, but real-world evidence remains crucial for confirming its profile in diverse populations. Methods: We have conducted a multicenter, retrospective observational study within the Spanish Psoriasis Group (GPS). This study updates previous findings with a larger sample size (n = 372) and longer follow-up. We assessed absolute Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA), and the Dermatology Life Quality Index (DLQI) improvements, as well as safety, in patients with moderate-to-severe plaque psoriasis. Results: The cohort included a large population of patients with a high prevalence of comorbidities and prior biologic exposure. Effectiveness was high, with a significant proportion of patients achieving PASI < 1. Compared to recent real-world data, our cohort demonstrates superior complete clearance rates (PASI < 1) and includes a comprehensive DLQI assessment. Notably, 79 patients were aged ≥65 years, confirming the drug’s utility in the elderly. Safety was consistent with previous reports, with no new signals detected. Conclusions: Tildrakizumab shows robust effectiveness and safety in a complex, bio-experienced real-world population. The lack of clinical predictors of response suggests a need for future pharmacogenetic exploration.
Open AccessReal-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)
Background: Tildrakizumab, an anti-IL-23p19 monoclonal antibody, has demonstrated efficacy in clinical trials, but real-world evidence remains crucial for confirming its profile in diverse populations. Methods: We have conducted a multicenter, retrospective observational study within the Spanish Psoriasis Group (GPS). This study updates previous findings with a larger sample size (n = 372) and longer follow-up. We assessed absolute Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA), and the Dermatology Life Quality Index (DLQI) improvements, as well as safety, in patients with moderate-to-severe plaque psoriasis. Results: The cohort included a large population of patients with a high prevalence of comorbidities and prior biologic exposure. Effectiveness was high, with a significant proportion of patients achieving PASI < 1. Compared to recent real-world data, our cohort demonstrates superior complete clearance rates (PASI < 1) and includes a comprehensive DLQI assessment. Notably, 79 patients were aged ≥65 years, confirming the drug’s utility in the elderly. Safety was consistent with previous reports, with no new signals detected. Conclusions: Tildrakizumab shows robust effectiveness and safety in a complex, bio-experienced real-world population. The lack of clinical predictors of response suggests a need for future pharmacogenetic exploration.
- 1 September 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (7) , 606-610
Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice
- 1 September 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (7) , 606-610
Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice
- 1 January 2018
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (1) , 78-80
Lupus eritematoso con afectación genital: una localización inusual
- 1 January 2018
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (1) , 78-80
Lupus eritematoso con afectación genital: una localización inusual
- Open Access
- 1 February 2016
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 96 (2) , 285-287
Alopecic Lesions on the Scalp in a Young Woman: A Quiz
- 1 February 2016
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 96 (2) , 285-287
Open AccessAlopecic Lesions on the Scalp in a Young Woman: A Quiz
- 1 September 2015
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 106 (7) , e33-e39
Tratamiento del síndrome de Sézary con alemtuzumab: serie de 5 casos y revisión de la literatura
- 1 September 2015
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 106 (7) , e33-e39
Tratamiento del síndrome de Sézary con alemtuzumab: serie de 5 casos y revisión de la literatura
- 22 May 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (6) , 637-639
A nodule on the scalp of an elderly patient
- 22 May 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (6) , 637-639
A nodule on the scalp of an elderly patient
- 22 December 2014
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (1) , 19-20
A reddish nodule on the nose
- 22 December 2014
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (1) , 19-20
A reddish nodule on the nose
- 30 September 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (2) , 219-221
Fever and skin lesions in an immunocompromised patient
- 30 September 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (2) , 219-221
Fever and skin lesions in an immunocompromised patient
- Open Access
- 1 August 2014
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 71 (2) , e49-e50
Supraumbilical cutaneous lesions after transcatheter arterial chemoembolization for hepatocellular carcinoma
- 1 August 2014
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 71 (2) , e49-e50
Open AccessSupraumbilical cutaneous lesions after transcatheter arterial chemoembolization for hepatocellular carcinoma
- Open Access
- 1 July 2014
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 94 (4) , 492-496
Purulent Discharge from the Nipples: A Quiz
- 1 July 2014
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 94 (4) , 492-496
Open AccessPurulent Discharge from the Nipples: A Quiz